NDC properties for "Tabloid 40 MG Oral Tablet" (RxCUI 105590)
About this data
The tables show NDC propoerties for Tabloid 40 MG Oral Tablet with the RxCUI 105590
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for Tabloid 40 MG Oral Tablet (RxCUI 105590)
| MMSL_CODE | BD3161 |
|---|---|
| NDA | NDA012429 |
| RxCUI | 105590 |
| SPL_SET_ID | 344df8bc-b16d-4b75-b4c8-40de7d465849 |
| SPL_SET_ID | 4490128b-e73f-4849-9d6e-e8591639d771 |
| SPL_SET_ID | 44b0c461-47fb-4106-ba11-6ed85530235c |
| Prescribable Synonym | TABLOID 40 MG Oral Tablet |
| RXNAV_STR | Tabloid 40 MG Oral Tablet |
| RxNorm Name | thioguanine 40 MG Oral Tablet [Tabloid] |
| RxNorm Synonym | Tabloid 40 MG Oral Tablet |
| Related queries | Interactions (for RxCUI 105590) |
NDC Properties
NDC Item 69784063025
| NDC 9 | 69784-630 |
|---|---|
| NDC 10 | 69784-630-25 |
| NDC Item | 69784063025 |
| Packaging | 1 BOTTLE in 1 CARTON (69784-630-25) / 25 TABLET in 1 BOTTLE |
| COLORTEXT | white(off-white) |
| Color | C48325 __ |
| FDA SPL set id | 682160 |
| Imprint code | T40 |
| Labeler | Woodward Pharma Services LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2022-06-30 |
| Marketing status | ACTIVE |
| NDA | NDA012429 |
| Score | 2 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 69784-630 |
NDC Item 76388088025
| NDC 9 | 76388-880 |
|---|---|
| NDC 10 | 76388-880-25 |
| NDC Item | 76388088025 |
| Packaging | 1 BOTTLE in 1 CARTON (76388-880-25) / 25 TABLET in 1 BOTTLE |
| COLORTEXT | white(off-white) |
| Color | C48325 __ |
| FDA SPL set id | 650307 |
| Imprint code | T40 |
| Labeler | Aspen Global Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2025-03-31 |
| Marketing effective time low | 2013-03-12 |
| Marketing status | COMPLETED |
| NDA | NDA012429 |
| Score | 2 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 76388-880 |
NDC Item 80725063025
| NDC 9 | 80725-630 |
|---|---|
| NDC 10 | 80725-630-25 |
| NDC Item | 80725063025 |
| Packaging | 1 BOTTLE in 1 CARTON (80725-630-25) / 25 TABLET in 1 BOTTLE |
| COLORTEXT | white(off-white) |
| Color | C48325 __ |
| FDA SPL set id | 710371 |
| Imprint code | T40 |
| Labeler | Waylis Therapeutics LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2023-05-15 |
| Marketing status | ACTIVE |
| NDA | NDA012429 |
| Score | 2 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 80725-630 |
NDC Item 69784063025
| NDC 9 | 69784-630 |
|---|---|
| NDC 10 | 69784-630-25 |
| NDC Item | 69784063025 |
| Packaging | 1 BOTTLE in 1 CARTON (69784-630-25) / 25 TABLET in 1 BOTTLE |
| COLORTEXT | white(off-white) |
| Color | C48325 __ |
| FDA SPL set id | 682160 |
| Imprint code | T40 |
| Labeler | Woodward Pharma Services LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2022-06-30 |
| Marketing status | ACTIVE |
| NDA | NDA012429 |
| Score | 2 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 69784-630 |
NDC Item 76388088025
| NDC 9 | 76388-880 |
|---|---|
| NDC 10 | 76388-880-25 |
| NDC Item | 76388088025 |
| Packaging | 1 BOTTLE in 1 CARTON (76388-880-25) / 25 TABLET in 1 BOTTLE |
| COLORTEXT | white(off-white) |
| Color | C48325 __ |
| FDA SPL set id | 650307 |
| Imprint code | T40 |
| Labeler | Aspen Global Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2025-03-31 |
| Marketing effective time low | 2013-03-12 |
| Marketing status | COMPLETED |
| NDA | NDA012429 |
| Score | 2 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 76388-880 |
NDC Item 80725063025
| NDC 9 | 80725-630 |
|---|---|
| NDC 10 | 80725-630-25 |
| NDC Item | 80725063025 |
| Packaging | 1 BOTTLE in 1 CARTON (80725-630-25) / 25 TABLET in 1 BOTTLE |
| COLORTEXT | white(off-white) |
| Color | C48325 __ |
| FDA SPL set id | 710371 |
| Imprint code | T40 |
| Labeler | Waylis Therapeutics LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2023-05-15 |
| Marketing status | ACTIVE |
| NDA | NDA012429 |
| Score | 2 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 80725-630 |
NDC Item 69784063025
| NDC 9 | 69784-630 |
|---|---|
| NDC 10 | 69784-630-25 |
| NDC Item | 69784063025 |
| Packaging | 1 BOTTLE in 1 CARTON (69784-630-25) / 25 TABLET in 1 BOTTLE |
| COLORTEXT | white(off-white) |
| Color | C48325 __ |
| FDA SPL set id | 682160 |
| Imprint code | T40 |
| Labeler | Woodward Pharma Services LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2022-06-30 |
| Marketing status | ACTIVE |
| NDA | NDA012429 |
| Score | 2 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 69784-630 |
NDC Item 76388088025
| NDC 9 | 76388-880 |
|---|---|
| NDC 10 | 76388-880-25 |
| NDC Item | 76388088025 |
| Packaging | 1 BOTTLE in 1 CARTON (76388-880-25) / 25 TABLET in 1 BOTTLE |
| COLORTEXT | white(off-white) |
| Color | C48325 __ |
| FDA SPL set id | 650307 |
| Imprint code | T40 |
| Labeler | Aspen Global Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2025-03-31 |
| Marketing effective time low | 2013-03-12 |
| Marketing status | COMPLETED |
| NDA | NDA012429 |
| Score | 2 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 76388-880 |
NDC Item 80725063025
| NDC 9 | 80725-630 |
|---|---|
| NDC 10 | 80725-630-25 |
| NDC Item | 80725063025 |
| Packaging | 1 BOTTLE in 1 CARTON (80725-630-25) / 25 TABLET in 1 BOTTLE |
| COLORTEXT | white(off-white) |
| Color | C48325 __ |
| FDA SPL set id | 710371 |
| Imprint code | T40 |
| Labeler | Waylis Therapeutics LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2023-05-15 |
| Marketing status | ACTIVE |
| NDA | NDA012429 |
| Score | 2 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 80725-630 |